Division

Pharmacology and Natural Products Division

The Pharmacology and Natural Products Division studies how medicines act and how they are used safely. Its scope includes therapeutics, medication safety and the evaluation of natural products as sources of new drugs.

8publications

2books

4registered studies

88credited people

Overview and scope

Key subject areas

Pharmacology, therapeutics, natural products and medication-related research.

Clinical pharmacology

Therapeutics

Natural product drug discovery

Pharmacovigilance and medication safety

Ethnopharmacology

Antimicrobial stewardship

Staff and contributors

People

Verified Sterling IMRES staff will be listed here. Until then, these are the people credited on this division’s library works (not institute staff).

All people in this division

Atanas G. Atanasov

Author

Works (2)

Pharmacology, Research

Silvio E. Inzucchi

Author

Works (2)

Clinical Medicine, Pharmacology

Aseel Abuzour

Author

Works (1)

Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis(2019)

Pharmacology, Clinical Medicine

Hisham Aljadhey

Author

Works (1)

What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature(2018)

Pharmacology, Clinical Medicine

Nouf Aloudah

Author

Works (1)

What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature(2018)

Pharmacology, Clinical Medicine

Inder S. Anand

Author

Works (1)

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction(2019)

Clinical Medicine, Pharmacology

Darren M Ashcroft

Author

Works (1)

Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis(2019)

Pharmacology, Clinical Medicine

Ghadah Asaad Assiri

Author

Works (1)

What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature(2018)

Pharmacology, Clinical Medicine

Active research

Registered studies

Research hub

UpcomingInterventionalPhase 1

A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults

University of Oxford

This University of Oxford Phase 1 study in Thailand will give healthy adult volunteers three regimens in randomised sequence: piperaquine alone, pyronaridine-artesunate alone, and all three drugs together. Each course runs for three days with follow-up and washout periods between regimens. The aim is to understand how the drugs interact before wider use of triple artemisinin-based combinations.

2026

RecruitingInterventionalPhase 1 / Phase 2

Curcumin and Retinal Study

Texas Tech University Health Sciences Center

This small randomised study at Texas Tech University Health Sciences Center gives participants either a low or a high dose of curcumin for two weeks. Retinal imaging is used to see whether curcumin crosses into nervous tissue and attaches to amyloid proteins. Researchers also look at safety, blood levels and gut bacteria.

2023

Completed and published

PublishedInterventional

Systolic Blood Pressure Intervention Trial

National Heart, Lung, and Blood Institute (NHLBI)

SPRINT was a large US multicentre randomised trial run by the NHLBI that compared two blood pressure targets in adults with hypertension. Participants were assigned either to an intensive systolic target or to the conventional target, and were followed for major cardiovascular events. Its main findings were published in the New England Journal of Medicine in 2015.

2010

PublishedInterventionalPhase 3

Longitudinal Antimalarial Combinations in Uganda

University of California, San Francisco

This Phase 3 study followed a cohort of young children in Kampala, Uganda, treating each malaria episode with one of three randomised drug combinations: amodiaquine plus artesunate, amodiaquine plus sulfadoxine-pyrimethamine, or artemether-lumefantrine. Following children over time allowed comparison of efficacy and safety across repeated treatments. Several results papers are linked in the registry.

2004

Publications and books